Suzhou Fengbei Biotech Stock Co., Ltd.SSE: 603334

Report for Q1 2026

Apr 29, 2026 · Issued by Suzhou Fengbei Biotech Stock Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 29, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-646

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Suzhou Fengbei Biotech Stock Co., Ltd. on 6ix

Earlier from Suzhou Fengbei Biotech Stock

Announcement on Circulation of Partial Restricted Shares in Offline Placement of Initial Public OfferingApr 28
Announcement on Opening Special Settlement Account for Cash Management of Raised FundsApr 24
Notice on Convening the 2025 Annual General MeetingApr 10
Announcement on Redemption at Maturity of Partial Idle Raised Funds Used for Cash ManagementApr 2
Announcement on Abnormal Fluctuations in Stock TradingFeb 6

Later from Suzhou Fengbei Biotech Stock

Announcement on Resolutions of the 2025 Annual General MeetingMay 8
Announcement on Convening Performance Briefing for 2025 and Q1 2026May 13
Announcement on Implementation of Dividend Distribution for 2025Jun 2
Announcement on Progress of Providing Guarantees for Wholly-owned SubsidiariesJun 17
Announcement on Redemption at Maturity of Certain Idle Raised Funds Used for Cash ManagementJul 31

All Suzhou Fengbei Biotech Stock news releases

Follow Suzhou Fengbei Biotech Stock into a list and get an email when it puts out news.

Follow Suzhou Fengbei Biotech Stock